ProjectManufacture and phase I clinical trial of HY-133, a recombinant phage lysin for rapid decolonization of…
Basic data
Title:
Manufacture and phase I clinical trial of HY-133, a recombinant phage lysin for rapid decolonization of Staphylococcus aureus from nasal habitats
Duration:
01/10/2021 to 31/12/2024
Abstract / short description:
Manufacture and phase I clinical trial of HY-133, a recombinant phage lysin for rapid decolonization of Staphylococcus aureus from nasal habitats
Involved staff
Managers
Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Interfaculty Institutes
Interfaculty Institutes
Cluster of Excellence: Controlling Microbes to Fight Infections (CMFI)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Local organizational units
Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Interfaculty Institutes
University of Tübingen
University of Tübingen
Funders
Braunschweig, Niedersachsen, Germany